In the BioHarmony Drug Report Database

"Preview" Icon

Balsalazide

Colazal, Giazo (balsalazide) is a small molecule pharmaceutical. Balsalazide was first approved as Colazal on 2000-07-18. It is used to treat ulcerative colitis in the USA. Colazal’s patents are valid until 2031-06-23 (FDA).

 

Trade Name

 

Colazal, Giazo
 

Common Name

 

balsalazide
 

ChEMBL ID

 

CHEMBL1201346
 

Indication

 

ulcerative colitis
 

Drug Class

 

Anti-inflammatory agents (salicylic acid derivatives)

Image (chem structure or protein)

Balsalazide structure rendering